PNC Financial Services Group
ORKA

PNC Financial Services Group’s Oruka Therapeutics ORKA Stock Holding History

PNC Financial Services Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Buy
4,225
+1,039
+33% +$69.2K ﹤0.01% 1955
2026
Q1 		$156K Buy
3,186
+1,736
+120% +$60.3K ﹤0.01% 2502
2025
Q4 		$44K Sell
1,450
-564
-28% -$15.7K ﹤0.01% 3285
2025
Q3 		$38.7K Buy
+2,014
New +$29.9K ﹤0.01% 3339
2023
Q3 		– Sell
-42
Closed -$1.01K – 4782
2023
Q2 		$1.01K Buy
+42
New +$1.03K ﹤0.01% 4509

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

PNC Financial Services Group's ORKA Position: Q2 2026 in Review

PNC Financial Services Group increased its Oruka Therapeutics (ORKA) stake by 33% in Q2 2026, buying an estimated $69.2K and bringing the position to 4,225 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

PNC Financial Services Group first reported a position in ORKA in Q2 2023 and has held it in 5 quarters since. 104 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • PNC Financial Services Group held 4,225 shares of Oruka Therapeutics worth $402K as of Q2 2026.
  • PNC Financial Services Group bought 1,039 Oruka Therapeutics shares in Q2 2026, an estimated $69.2K.
  • Oruka Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1955 holding.
  • PNC Financial Services Group first reported a position in Oruka Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • 104 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.